The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. — Columbus, Ohio

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has participated in 3 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Triple Negative Breast Cancer, Non-Hodgkin's Lymphoma.

Sponsors: Genentech, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc.?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. conducted?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has 3 clinical trials on record. Their work covers Metastatic Breast Cancer, Triple Negative Breast Cancer, Non-Hodgkin's Lymphoma.

Is The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. accredited by Crixeo Health?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.